Cytokine G-protein signaling crosstalk in cardiomyocytes: Attenuation of Jak-STAT activation by endothelin-1

Molecular and Cellular Biochemistry

Volumn 240, Issue 1-2, 2002, Pages 39-46

  Booz, George W ^a   Day, Jonathan N E ^a   Speth, R ^b   Baker, Kenneth M ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Cardiomyocyte; Endothelin; ERK 1 and 2; Jak STAT; Leukemia inhibitory factor; LIF receptor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CARDIOTROPHIN 1; CYTOKINE; ENDOTHELIN 1; GLYCOPROTEIN GP 130; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 6; JANUS KINASE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PEPTIDE HORMONE; PROTEINASE INHIBITOR; RADIOLIGAND; RECEPTOR SUBUNIT; STAT PROTEIN; STAT3 PROTEIN; TYROSINE; CYTOKINE RECEPTOR; DNA BINDING PROTEIN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; JAK1 PROTEIN, RAT; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA; LIFR PROTEIN, RAT; PROTEIN TYROSINE KINASE; STAT3 PROTEIN, RAT; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ATTENUATION; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; ENZYME INHIBITION; HEART MUSCLE CELL; HEART VENTRICLE; HEART VENTRICLE HYPERTROPHY; LIGAND BINDING; NEWBORN; NONHUMAN; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ARTICLE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; HEART MUSCLE; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

ANIMALIA; JANUS;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; DNA-BINDING PROTEINS; ENDOTHELIN-1; ENZYME ACTIVATION; HETEROTRIMERIC GTP-BINDING PROTEINS; JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR CROSS-TALK; RECEPTORS, CYTOKINE; RECEPTORS, OSM-LIF; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0036854873     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020648425895     Document Type: Review

References (25)

1. Booz GW, Baker KM: Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 28: 635-640, 1996
2. Fukuzawa J, Booz GW, Hunt RA, Shimizu N, Karoor V, Baker KM, Dostal DE: Cardiotrophin-1 increases angiotensinogen mRNA in rat cardiac myocytes through STAT3: An autocrine loop for hypertrophy. Hypertension 35: 1191-1196, 2000
3. Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR: Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. J Biol Chem 271: 9535-9545, 1996
4. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR: Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 272: 5783-5791, 1997
5. Sheng Z, Pennica D, Wood WI, Chien KR: Cardiotrophin-1 displays early expression in the murine heart tube and promotes cardiac myocyte survival. Development 122: 419-428, 1996
6. Tone E, Kunisada K, Fujio Y, Matsui H, Negoro S, Oh H, Kishimoto T, Yamauchi-Takihara K: Angiotensin II interferes witl leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes. Biochem Biophys Res Commun 253: 147-150, 1998
7. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L: Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998
8. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S: Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 275: 29717-29723, 2000
9. Saito S, Aikawa R, Shiojima I, Nagai R, Yazaki Y, Komuro I: Endothelin-1 induces expression of fetal genes through the interleukin-6 family of cytokines in cardiac myocytes. FEBS Lett 456: 103-107, 1999
10. Schiemann WP, Graves LM, Baumann H, Morella KK, Gearing DP, Nielsen MD, Krebs EG, Nathanson NM: Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc Natl Acad Sci USA 92: 5361-5365, 1995
11. Blanchard F, Duplomb L, Wang Y, Robledo O, Kinzie E, Pitard V, Godard A, Jacques Y, Baumann H: Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J Biol Chem 275: 28793-28801, 2000
12. Aoki H, Richmond M, Izumo S, Sadoshima J: Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro. Biochem J 347: 275-284, 2000
13. Pellegrini S, Dusanter-Fourt I: The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur J Biochem 248: 615-633, 1997
14. Wen Z, Zhong Z, Darnell JE Jr: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250, 1995
15. Terstegen L, Gatsios P, Bode JG, Schaper F, Heinrich PC, Graeve L: The inhibition of interleukin-6-dependent STAT activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130. J Biol Chem 275: 18810-18817, 2000
16. Chung J, Uchida E, Grammer TC, Blenis J: STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 17: 6508-6516, 1997
17. Jain N, Zhang T, Fong SL, Lim CP, Cao X: Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene 17: 3157-3167, 1998
18. Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T: Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98: 346-352, 1998
19. Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH: Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy. J Biol Chem 275: 37895-37901, 2000
20. Hirota H, Chen J, Betz UA, Rajewsky K, Gu Y, Ross J Jr, Muller W, Chien KR: Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97: 189-198, 1999
21. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Eng J Med 341: 1276-1283, 1999
22. Kunisada K, Negoro S, Tone E, Funamoto M, Osugi T, Yamada S, Okabe M, Kishimoto T, Yamauchi-Takihara K: Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc Natl Acad Sci USA 97: 315-319, 2000
23. Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS, Knight RA, Latchman DS: Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 275: 10002-10008, 2000
24. Giannessi D, Del Ry S, Vitale RL: The role of endothelins and their receptors in heart failure. Pharmacol Res 43: 111-126, 2001
25. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353-355, 1996